Lou Gehrig’s disease, formally called amyotrophic lateral sclerosis (ALS), produces a progressive loss of voluntary muscle control that usually begins with subtle weakness or clumsiness in one part of the body and spreads outward over months and years. The hallmark symptoms include muscle wasting, stiffness, twitching, difficulty speaking or swallowing, and eventually breathing problems. But the full picture extends well beyond muscles: many people with ALS also experience cognitive changes, involuntary episodes of laughing or crying, pain, sleep disruption, and autonomic irregularities that are often underappreciated.
How Symptoms Typically Begin
ALS does not announce itself with a single, unmistakable symptom. The disease generally starts in one of two ways, depending on which motor neurons degenerate first. In about two-thirds of cases, weakness begins in a limb. You might notice a foot that drags, a hand that fumbles with buttons, or a grip that weakens over weeks without an obvious injury. In the remaining cases, the first signs involve the muscles of the mouth and throat, a pattern called bulbar onset. Slurred speech, a change in voice quality, and difficulty swallowing are the earliest clues.1PubMed Central. Sustained Bulbar and Respiratory Function in a Case Most Consistent With Bulbar-Onset Amyotrophic Lateral Sclerosis Following Axial Spinal Traction: A 21-Month Report In one reported case, a sixty-year-old woman developed sudden slurring of speech, tongue deviation, and progressive swallowing difficulty that started with solid food and moved to softer textures over eight months.2PubMed Central. Bulbar onset amyotrophic lateral sclerosis: A case report
Regardless of where it starts, the weakness is typically asymmetric at first. One arm or one leg might feel off while the other side seems fine. People often attribute early symptoms to aging, a pinched nerve, or overuse. That intuition is understandable but can delay the path to diagnosis by months or longer.
Muscle Weakness, Stiffness, and Fasciculations
Classical ALS involves the breakdown of two distinct populations of nerve cells at the same time. The upper motor neurons, which run from the brain down through the spinal cord, normally keep muscle tone in check. When they fail, muscles become stiff and reflexes become exaggerated, a state called spasticity. The lower motor neurons, which connect the spinal cord directly to the muscles, are responsible for activating those muscles. When they degenerate, muscles shrink and weaken.3PubMed Central. Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS) Most people with ALS eventually show signs of both types of nerve cell damage, though the balance between stiffness and wasting varies from person to person.
Fasciculations, the visible muscle twitches that ripple under the skin, are one of the more anxiety-provoking symptoms for patients and onlookers alike. They happen because dying motor neurons fire erratically before they go silent altogether. Research comparing fasciculation rates in ALS with those in benign fasciculation syndrome found that ALS-affected muscles twitch far more frequently, up to ten times the normal rate in muscles that are still strong and even higher in muscles that have begun to weaken. As the muscle deteriorates further, the twitching rate actually falls, because fewer nerve cells remain to misfire.4PubMed Central. The rise and fall of fasciculations in amyotrophic lateral sclerosis That rise-and-fall pattern is a useful clinical insight: fasciculations alone are common and usually harmless, but fasciculations paired with progressive weakness paint a different picture.
Speech and Swallowing Problems
Bulbar symptoms can appear at any stage, whether or not the disease started in the limbs. When the motor neurons controlling the tongue, lips, palate, and larynx deteriorate, speech becomes slurred or nasal, and volume drops. Tongue fasciculations and incomplete closure of the vocal folds are common findings on clinical examination.5PubMed. Otolaryngologic presentations of amyotrophic lateral sclerosis Swallowing weakens in a predictable order for many patients: solid foods become hard to manage first, then softer textures, then liquids.2PubMed Central. Bulbar onset amyotrophic lateral sclerosis: A case report
These changes carry serious practical consequences. Meals take longer, choking episodes become frequent, and weight loss can accelerate rapidly. Many patients eventually need a feeding tube to maintain adequate nutrition and reduce the risk of aspiration pneumonia. For people with bulbar-onset ALS, speech and swallowing difficulties define the early illness experience, often before any noticeable limb weakness has appeared.
Breathing Difficulties
The diaphragm, the dome-shaped muscle beneath the lungs, is the primary breathing muscle, and it is not spared by ALS. As the motor neurons controlling it weaken, lung capacity drops, the chest wall does not expand as well, and oxygen exchange becomes less efficient. Early respiratory involvement may show up only as breathlessness when lying flat, because gravity makes the weakened diaphragm work harder in that position.6PubMed Central. Respiratory therapies for Amyotrophic Lateral Sclerosis: A state of the art review Morning headaches and daytime drowsiness can also signal that breathing is becoming inadequate during sleep, well before a person feels overtly short of breath during the day.
As the respiratory muscles continue to weaken, the ability to cough effectively declines. Secretions accumulate in the airways, and the risk of lung infections climbs. Chronic respiratory insufficiency is ultimately the primary cause of death in most people with ALS. Non-invasive ventilation, a mask-delivered breathing support worn especially at night, can help maintain oxygen levels and improve quality of life, but monitoring lung function regularly is critical for timing that intervention.
Cognitive and Behavioral Changes
ALS was once considered a purely motor disease, leaving the mind intact while the body failed. That understanding has shifted substantially. Research now shows that cognitive changes occur in up to about two-thirds of ALS patients, ranging from subtle difficulties with planning and decision-making to problems with language and social awareness. Roughly one in seven patients develops full-blown dementia, overlapping heavily with a condition called frontotemporal dementia.7PubMed Central. Cognitive and Behavioral Manifestations in ALS: Beyond Motor System Involvement
Behavioral symptoms can include apathy, loss of empathy, impulsivity, and a reduced ability to read social cues. These changes are not simply a reaction to living with a devastating diagnosis. They stem from degeneration of the frontal and temporal brain regions that regulate personality and social behavior. For caregivers, the behavioral shifts can be among the most distressing aspects of the illness, particularly when they are mistaken for depression or stubbornness rather than recognized as part of the disease process.
Pathological Laughing and Crying
A distinctive symptom that catches many patients and families off guard is involuntary emotional expression, sometimes called pseudobulbar affect. People with ALS may burst into laughter or tears with little or no emotional provocation, or the emotional response may be wildly disproportionate to the situation. The crying or laughter can feel uncontrollable and embarrassing, even though the person does not necessarily feel the emotion their face is expressing.
This phenomenon is driven by degeneration of the brainstem and white-matter pathways that normally regulate emotional responses. Imaging studies have linked the frequency of pathological laughter to reduced brainstem volume, with the midbrain and pons particularly implicated.8Frontiers in Neurology. Brainstem Correlates of Pathological Laughter and Crying Frequency in ALS Other research has identified white-matter changes in frontotemporal regions and structures connecting the cerebellum to the brainstem in patients with this symptom.9PubMed Central. Pathological Crying and Laughing in Motor Neuron Disease: Pathobiology, Screening, Intervention Medication can reduce the episodes, which is worth knowing because many patients and families assume nothing can be done about it.
Pain Is More Common Than People Expect
Because ALS primarily damages motor neurons, there is a widespread assumption that it is not a painful condition. That assumption is wrong. Pain affects a large proportion of ALS patients and comes from several sources. Muscle cramps and spasticity can cause direct, sometimes severe discomfort. As muscles waste away, the joints they once supported lose their scaffolding, leading to aching in the shoulders, hips, and back. Prolonged immobility compounds the problem, causing degenerative changes in joints and connective tissue.10Journal of Yeungnam Medical Science. Pain in amyotrophic lateral sclerosis: A narrative review
Pain in ALS tends to worsen as the disease advances and immobility increases. Neuropathic pain, which feels like burning or tingling, also occurs in some patients. For those on long-term ventilatory support, the mask or tracheostomy interface itself can become a source of discomfort. Treating pain aggressively matters not only for comfort but because uncontrolled pain disturbs sleep, worsens fatigue, and erodes the quality of life that supportive care is trying to preserve.
Sleep Disruption and Autonomic Irregularities
Poor sleep is almost universal in ALS, and its causes are layered. Weakened breathing muscles lead to drops in blood oxygen during the night, particularly during dreaming sleep when the body naturally relaxes its respiratory effort. Studies have found that a meaningful number of ALS patients meet criteria for moderate to severe obstructive sleep apnea, with oxygen levels dipping below safe thresholds during the night.11Annals of Community Medicine and Practice. Sleep, Sleep Structure and Sleep Disorders in a Cohort of Patients Affected by ALS Morning headaches, excessive daytime sleepiness, and difficulty concentrating can all be downstream effects of disrupted nighttime breathing.
Less widely appreciated is that ALS can also disturb the autonomic nervous system, which controls functions you do not consciously think about. Patients often report abnormal sweating patterns, such as excessive sweating in the palms early in the disease and reduced sweating later, as well as skin temperature changes and skin discoloration. Research suggests these symptoms reflect an imbalance in the sympathetic nervous system, with early overactivity giving way to progressive peripheral nerve dysfunction as the disease advances.12European Neurological Review. Sympathetic Hyperactivity and Sympathovagal Imbalance in Amyotrophic Lateral Sclerosis
How Sex and Age Shape the Symptom Profile
ALS does not look exactly the same in everyone, and some of that variation tracks with sex and age at onset. Men are somewhat more likely to develop ALS overall, and the disease in men tends to begin in the limbs, particularly the arms and legs.13PubMed. Effects of gender in amyotrophic lateral sclerosis Women, by contrast, are more likely to experience bulbar-onset ALS, especially as age at diagnosis increases.14PubMed. ALS phenotype is influenced by age, sex, and genetics: A population-based study That distinction has practical consequences: bulbar onset tends to carry a faster progression and is associated with a worse prognosis.
Population-level data also show that particular subtypes cluster differently by sex. The flail-arm pattern, where weakness is concentrated in both arms with less involvement elsewhere, is more common in men, as is the respiratory-onset form. The flail-leg pattern, where weakness centers on one or both legs, skews male especially at older ages.14PubMed. ALS phenotype is influenced by age, sex, and genetics: A population-based study Among patients whose disease starts later in life, both men and women tend to have lower lung function at the time of initial examination compared to younger-onset patients, which can accelerate the timeline to needing ventilatory support.15PubMed. Gender differences in clinical features at the initial examination of late-onset amyotrophic lateral sclerosis
Why Diagnosis Takes So Long
Given how varied the early symptoms can be, it is unsurprising that getting an ALS diagnosis takes a long time. An analysis of over twenty retrospective studies found that the typical interval from symptom onset to diagnosis ranges from about ten to sixteen months on average, with some patients waiting over two years. Patients themselves often wait three to six months before seeking medical attention, because the initial symptoms feel minor or attributable to something else.16The American Journal of Managed Care. Pathogenesis and Presentation of ALS: Examining Reasons for Delayed Diagnosis and Identifying Opportunities for Improvement
Even after a doctor visit, the path often detours through the wrong specialists. Primary care providers frequently refer patients to orthopedic surgeons, neurosurgeons, or rheumatologists rather than to a neurologist experienced in motor neuron disease. Misdiagnosis rates are strikingly high: studies report that anywhere from about one in eight to more than two-thirds of patients receive an incorrect initial diagnosis, most commonly cerebrovascular disease, cervical spine problems, or nerve compression syndromes. Some of these misdiagnosed patients undergo unnecessary surgery before the correct diagnosis is made.16The American Journal of Managed Care. Pathogenesis and Presentation of ALS: Examining Reasons for Delayed Diagnosis and Identifying Opportunities for Improvement Other neurodegenerative conditions, including Parkinson’s disease, spinal muscular atrophy, and frontotemporal dementia, can mimic ALS features closely enough to lead clinicians astray.17Neurodegenerative Diseases. The Big Bluff of Amyotrophic Lateral Sclerosis Diagnosis: The Role of Neurodegenerative Disease Mimics
There is no single blood test or scan that confirms ALS. Diagnosis relies on clinical examination, electromyography, and the exclusion of other conditions, which takes time and expertise. Patients who are referred early to a neurologist with experience in motor neuron disease tend to receive a faster diagnosis, which has real implications for starting supportive treatments sooner and planning ahead.
Atypical Variants and Juvenile Forms
ALS is not one uniform disease. Beyond the classical pattern, several recognized variants present with unusual symptom distributions. Flail-arm syndrome centers weakness in both shoulders and upper arms while leaving the legs relatively intact for longer. Flail-leg syndrome does the opposite. Primary lateral sclerosis involves mainly the upper motor neurons, leading to profound stiffness but slower muscle wasting, while progressive muscular atrophy targets primarily the lower motor neurons. Rarer entities include facial-onset sensory and motor neuronopathy, which begins with numbness and weakness in the face rather than the limbs.18PubMed. Atypical Motor Neuron Disease variants: Still a diagnostic challenge in Neurology These variants can progress more slowly or more quickly than classical ALS, and they sometimes escape diagnosis for even longer because they do not match the textbook description.
ALS can also appear in young people, though this is rare. Juvenile ALS, defined broadly as onset before age 25, often looks different from the adult form. One genetic subtype shows a slowly progressive course with an average age of onset around sixteen years, typically starting with weakness in the feet and difficulty walking. Hands weaken next, followed gradually by the arms and legs more broadly. Bulbar and respiratory function tend to be spared for much longer than in adult-onset disease.19PubMed Central. Juvenile Amyotrophic Lateral Sclerosis: A Review The slower progression means some of these patients live for decades, a very different trajectory from the three-to-five-year median survival commonly cited for adult ALS.
How Genetics Influence the Symptom Picture
About 5 to 10 percent of ALS cases are familial, meaning a known genetic mutation runs in the family. The rest are classified as sporadic, though genetic risk factors play a role even in those cases. What is increasingly clear is that which gene is involved can influence which symptoms dominate. Mutations in the C9orf72 gene, the most common genetic cause of ALS in people of European descent, are strongly associated with cognitive and behavioral symptoms, including psychotic features and aggression, essentially pushing the disease toward the frontotemporal dementia end of the spectrum.20PubMed Central. The Differential Effects of Genetic Mutations in ALS and FTD Genes on Behavioural and Cognitive Changes: A Systematic Review and Meta-Analysis In contrast, mutations in the SOD1 gene, one of the first ALS genes identified, tend to spare cognition and produce a more purely motor picture.
Even within a single gene, different mutations produce different outcomes. Among SOD1 mutations that alter the length of the protein, those located closer to one end of the molecule are associated with earlier disease onset and shorter survival, while others allow for a more slowly progressive course. The clinical picture can vary substantially even among family members carrying the same mutation.21PubMed Central. Phenotypic Characterization of ALS-Causing SOD1 Mutations Affecting Polypeptide Length This variability is frustrating for families seeking clear predictions but also a reminder that the disease interacts with a constellation of factors beyond a single gene. As genetic testing becomes more common in ALS clinics, the specific mutation involved is starting to inform which symptoms to monitor for and, increasingly, which targeted therapies might apply.